Ciara Reilly

Title: Ciara Reilly: Innovator in Antibody Development

Introduction

Ciara Reilly is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents to her name, her work focuses on innovative solutions for treating diseases.

Latest Patents

Ciara's latest patents include groundbreaking inventions related to tumor necrosis factor-like ligand 1A specific antibodies. The first patent provides antibodies, or antigen-binding fragments thereof, which specifically bind to tumor necrosis factor (TNF)-like ligand (TL1A). This invention also outlines a method for obtaining such antibodies and nucleic acids encoding them. Furthermore, it relates to compositions and therapeutic methods for using these antibodies in the treatment and prevention of TL1A-mediated diseases, disorders, or conditions. The second patent mirrors the first, focusing on tumor necrosis factor-like ligand A (TLA) and its therapeutic applications.

Career Highlights

Throughout her career, Ciara has worked with leading pharmaceutical companies, including Pfizer Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to refine her expertise in antibody development and therapeutic applications.

Collaborations

Ciara has collaborated with notable professionals in her field, including Robert Arch and Jun Zhang. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Ciara Reilly is a trailblazer in the field of biotechnology, with a focus on antibody development for therapeutic use. Her contributions are paving the way for advancements in the treatment of various diseases.